Fresh Improvers Sep 2026

The Fresh Improvers Sep 2026 portfolio delivers a dynamic mix of growth stocks designed to capture upside in the 2026 market outlook. With holdings like Marker Therapeutics Inc (MRKR), Funko Inc (FNKO), Intapp Inc (INTA), Mobile Infrastructure Corporation (BEEP), and eXoZymes Inc (EXOZ), this score-based strategy targets undervalued stocks across healthcare stocks, consumer cyclical names, and technology sector leaders. Each position at 11.1% creates balanced exposure that serves as a compelling sector ETF alternative while focusing on companies positioned for earnings improvement and market expansion in Q1 2026. Ideal for investors seeking aggressive growth beyond traditional dividend income or value investing approaches, the portfolio blends healthcare stocks like MRKR and EXOZ with consumer favorites such as FNKO and BRCB to pursue capital appreciation. Its 74.1 diversification score supports steady accumulation, yet the 45.82 Tradestie Score signals notable volatility tied to small-cap and emerging names. Market risks including sector-specific factors in technology and consumer cyclical areas, plus broader economic shifts, make this suitable for those with higher risk tolerance. Passive income seekers should note the emphasis on growth over dividends, requiring active monitoring through 2026.